BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16246825)

  • 1. Left ventricular hypertrophy, apoptosis, and progression to heart failure in severe aortic stenosis.
    Anselmi A; Lotrionte M; Biondi-Zoccai GG; Galiuto L; Abbate A
    Eur Heart J; 2005 Dec; 26(24):2747. PubMed ID: 16246825
    [No Abstract]   [Full Text] [Related]  

  • 2. Aortic stenosis: from pressure overload to heart failure.
    Carabello BA
    Heart Fail Clin; 2006 Oct; 2(4):435-42. PubMed ID: 17448430
    [No Abstract]   [Full Text] [Related]  

  • 3. Iconoclasts topple adaptive myocardial hypertrophy in aortic stenosis.
    Buermans HP; Paulus WJ
    Eur Heart J; 2005 Sep; 26(17):1697-9. PubMed ID: 15911565
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of apoptotic caspase cascade during the transition to pressure overload-induced heart failure.
    Moorjani N; Ahmad M; Catarino P; Brittin R; Trabzuni D; Al-Mohanna F; Narula N; Narula J; Westaby S
    J Am Coll Cardiol; 2006 Oct; 48(7):1451-8. PubMed ID: 17010810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respective impacts of aortic stenosis and systemic hypertension on left ventricular hypertrophy.
    Garcia D; Pibarot P; Kadem L; Durand LG
    J Biomech; 2007; 40(5):972-80. PubMed ID: 16750211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial apoptosis predicts postoperative course after aortic valve replacement in patients with severe left ventricular hypertrophy.
    Gaudino M; Anselmi A; Abbate A; Galiuto L; Luciani N; Glieca F; Possati G
    J Heart Valve Dis; 2007 Jul; 16(4):344-8. PubMed ID: 17702357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined aortic stenosis and regurgitation: double the trouble.
    Ong G; Pibarot P
    Heart; 2019 Oct; 105(19):1515-1522. PubMed ID: 31142591
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor necrosis factor-induced signal transduction and left ventricular remodeling.
    Mann DL
    J Card Fail; 2002 Dec; 8(6 Suppl):S379-86. PubMed ID: 12555149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aortic valve replacement in patients with heart failure].
    Banach M; Okoński P; Kośmider A; Irzmański R; Rysz J; Olszewski R; Zwoliński R; Zasłonka J
    Pol Merkur Lekarski; 2006 Jun; 20(120):642-5. PubMed ID: 17007258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiologic role of myocardial hypertrophy, microcirculatory dysfunction and cardiomyocyte apoptosis in aortic stenosis].
    Lotrionte M; Galiuto L; Biondi-Zoccai GG; Abbate A
    G Ital Cardiol (Rome); 2006 Jul; 7(7):437-44. PubMed ID: 16977783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing heart failure in aortic valve stenosis.
    Jolobe OM
    J Intern Med; 2005 May; 257(5):484. PubMed ID: 15836669
    [No Abstract]   [Full Text] [Related]  

  • 13. Left ventricular mass: impact on left ventricular contractile function and its reversibility in patients undergoing aortic valve replacement.
    Taniguchi K; Takahashi T; Toda K; Matsue H; Shudo Y; Shintani H; Mitsuno M; Sawa Y
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):588-95. PubMed ID: 17689973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The decrease in QRS amplitude after aortic valve replacement in patients with aortic valve stenosis.
    Kurisu S; Inoue I; Kawagoe T; Ishihara M; Shimatani Y; Nakama Y; Maruhashi T; Kagawa E; Dai K; Matsushita J; Ikenaga H
    J Electrocardiol; 2009; 42(5):410-3. PubMed ID: 19368931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling.
    Nishio R; Matsumori A
    Circ Res; 2009 Apr; 104(7):829-31. PubMed ID: 19359605
    [No Abstract]   [Full Text] [Related]  

  • 16. A 61-year-old patient presenting with new onset heart failure: managing low flow, low gradient aortic stenosis.
    Fontes-Carvalho R
    Eur Heart J; 2013 Feb; 34(7):548. PubMed ID: 23242194
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heart insufficiency in aortic valve disease: prognosis and treatment].
    Santibáñez Escobar F
    Arch Cardiol Mex; 2002; 72 Suppl 1():S212-5. PubMed ID: 12001848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
    Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
    Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Fas in the progression of ischemic heart failure: prohypertrophy or proapoptosis.
    Feng QZ; Zhao YS; Abdelwahid E
    Coron Artery Dis; 2008 Nov; 19(7):527-34. PubMed ID: 18923250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prosthesis-patient mismatch after aortic valve replacement predominantly affects patients with preexisting left ventricular dysfunction: effect on survival, freedom from heart failure, and left ventricular mass regression.
    Ruel M; Al-Faleh H; Kulik A; Chan KL; Mesana TG; Burwash IG
    J Thorac Cardiovasc Surg; 2006 May; 131(5):1036-44. PubMed ID: 16678587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.